Scaar

From Wikipedia, the free encyclopedia
Jump to: navigation, search

SCAAR (Swedish Coronary Angiography and Angioplasty Register) [1]

The SCAAR is a Swedish national registry that contains relevant medical data on consecutive patients from 29 hospitals in Sweden at which coronary angiography and PCI (percutaneous coronary interventions) are performed. The registry was established in 1989. It is sponsored by the National Board of Health and Welfare and is independent of funding from industry. The data technology was developed by, and is administered by the Uppsala Clinical Research Center ([2]). Since 2001, SCAAR has been Internet-based, with recording of data online through a Web interface. Data are transferred in an encrypted format to a central server at the Uppsala Clinical Research Center. All consecutive patients undergoing coronary angiography or PCI in Sweden are registered in this database which provides a unique opportunity for prospective observational studies within the field of interventional cardiology.

List of publications[edit]

  1. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-19.
  2. Carlsson J, von Wagenheim B, Linder R, Anwari TM, Qvist J, Petersson I, Magounakis T, Lagerqvist B. Is late stent thrombosis in drug-eluting stents a real clinical issue? : A single-center experience and review of the literature.Clin Res Cardiol 2007 Feb; 96(2):86-93.
  3. Per Liss, Pontus B. Persson, Peter Hansell, and Bo Lagerqvist. Renal failure in 57,925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006 Nov; 70(10):1811-7.
  4. Jörg Carlsson, Stefan N James, Elisabeth Ståhle and Bo Lagerqvist Outcome of percutaneous coronary intervention in hospitals with and without on-site cardiac surgery standby. Heart 2007 Mar;93(3):335-8
  5. Per Tornvall, Tage Nilsson and Bo Lagerqvist. Effects on mortality of abciximab in ST-elevation myocardial infarction treated with percutaneous coronary intervention including stent implantation. J Intern Med 2006 Oct;260 (4):363-8.
  6. Jens Jensen, Bo Lagerqvist, Mikael Aasa, Toomas Särev, Tage Nilsson, Per Tornvall Clinical and Angiographic Follow-up after Coronary Drug-Eluting and Bare Metal Stent Implantation. Does Drug-Eluting Stents hold the promise? J Intern Med 2006 Aug;260(2):118-24.
  7. Lambe M, Hall P, Granath F, Azodi O, Nilsson T. Coronary angioplasty and cancer risk: a population-based cohort study in Sweden. Cardiovasc Intervent Radiol 2005;28(1):36-8.
  8. Haglund B, Köster M, Nilsson T, Rosén M. Inequality in Access to Bypass Surgery in Sweden. Scand Cardiovasc J 2004;38:334-9.
  9. Stenestrand U, Wallentin L, for the RIKS-HIA group. Early revascularization and 1-year survival in 14-days survivors of acute myocardial infarction: A prospective cohort study. Lancet 2002;359:1805-11
  10. Nilsson T, Bergfeldt L, Åberg B, Hultman J, Svensson S, Wallentin L. Policydokument. Kateterburen diagnostik och behandling av kranskärlssjukdom. Läkartidningen 2001;98:303-5.
  11. Wallentin L, Nilsson T, Bergfeldt L, Thorvinger B, Held C, Bergstrand L, Nilsson G, Fransson S, Sonnhag C, Albertsson P. Önskvärt att öka användandet av perkutan kranskärlsintervention. 400 interventioner per år minimivolym vid decentralisering av verksamheten. Läkartidningen 1999;96:4928-32.